Huszonek J J
Department of Psychiatry & Behavioral Sciences, S.U.N.Y. Health Science Center at Syracuse 13210, USA.
J Geriatr Psychiatry Neurol. 1995 Apr;8(2):100-2. doi: 10.1177/089198879500800204.
Depression is commonly associated with idiopathic Parkinson's disease. Various antidepressants can be helpful in the treatment of this type of depression. Anticholinergic medications are at times used for treating the motor symptoms of parkinsonism. While some authors have reported euphorigenic effects from anticholinergics in other groups of patients, generally, they have not been used in the treatment of depression, with or without parkinsonism. In the case presented, a depressed patient with Parkinson's disease on levodopa/carbidopa and fluoxetine was given benztropine for his motor symptoms. The result was some improvement in his motor symptoms and a wide, dose-related spectrum of other central nervous system changes ranging from delirium to mania, hypomania, and euthymia from a "baseline" of residual depression. At a very low dose (0.25 mg per day), benztropine appeared to have an augmenting antidepressant effect that rendered the patient euthymic.
抑郁症通常与特发性帕金森病相关。各种抗抑郁药有助于治疗此类抑郁症。抗胆碱能药物有时用于治疗帕金森病的运动症状。虽然一些作者报告了抗胆碱能药物在其他患者群体中产生欣快效应,但总体而言,无论有无帕金森病,它们都未用于治疗抑郁症。在本文所述病例中,一名患有帕金森病且正在服用左旋多巴/卡比多巴和氟西汀的抑郁症患者,因其运动症状而服用了苯海索。结果是他的运动症状有所改善,并且出现了一系列与剂量相关的其他中枢神经系统变化,范围从谵妄到躁狂、轻躁狂,以及从残留抑郁的“基线”转变为心境正常。在非常低的剂量(每天0.25毫克)下,苯海索似乎具有增强抗抑郁作用,使患者心境正常。